Patient Research Cohort –Rapidly Evolving Multiple Sclerosis (PRC-REMS) study. We are close to completing patient recruitment (n = 178 out of target n = 200) in a Medical Research Council-(MRC)-funded Patient Research Cohort on rapidly evolving multiple sclerosis (MS), the first cohort of this kind in the UK. The objectives of the study are to extensively characterise a group of MS patients with rapidly progressing disease through clinical, imaging and immunological studies aimed at identifying biomarkers associated with progression of disability; and facilitate development of and participation to other clinical trials.
PRC-REMS PI: Dr Paolo Muraro
PI: Dr Paolo Muraro